Variant BA. 2.86 and its descendant, JN. 1, of SARS-CoV-2 are rising in incidence across
Europe and globally. We isolated recent JN. 1, BA. 2.86, EG. 5, XBB. 1.5 and earlier variants …

Ongoing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) evolution has
given rise to recombinant Omicron lineages that dominate globally (XBB. 1), as well as the …

SARS-CoV-2 variants acquire mutations in spike that promote immune evasion and impact
other properties that contribute to viral fitness such as ACE2 receptor binding and cell entry …

The rapid evolution of SARS-CoV-2 is driven in part by a need to evade the antibody
response in the face of high levels of immunity. Here, we isolate spike (S) binding …

Since the SARS-CoV-2 Omicron virus has gained dominance worldwide, its continual
evolution with unpredictable mutations and patterns has revoked all authorized …

The latest wave of SARS-CoV-2 Omicron variants displayed a growth advantage and
increased viral fitness through convergent evolution of functional hotspots that work …

SARS-CoV-2 variants acquire mutations in the spike protein that promote immune evasion
and affect other properties that contribute to viral fitness, such as ACE2 receptor binding and …

The fundamental biology of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
nucleocapsid protein (Ncap), its use in diagnostic assays and its potential application as a …

The avian Gammacoronavirus infectious bronchitis virus (IBV) causes major economic
losses in the poultry industry as the aetiological agent of infectious bronchitis, a highly …

Omicron surged as a variant of concern in late 2021. Several distinct Omicron variants
appeared and overtook each other. We combined variant frequencies and infection …